MUC1 and interstitial lung disease: It is a substance produced by Type II alveolar epithelial cells in the lungs, is now classified as a human MUC1 mucin protein, and regenerating Type II pneumocytes are the primary cellular source of KL-6/MUC1 in the affected lungs of patients with interstitial lung diseases (ILDs) [1, 2].